| Combining molecular profiling of expressed genes in tumour tissue with advanced bioinformatics tools is beginning to show its power in revealing disease characteristics that are otherwise indistinguishable. This can be used to refine current tumour classification methods and allows for a more accurate prediction for patients of the disease outcome. Using molecular profiling, treatment schemes can be tailored to the patient's needs. This research theme will focus on four main tumor types: breast cancer, melanoma, lymphoma and prostate cancer. |
